News
Drug and biotech news
Last checked: Nov 20, 2026Source: BioPharma Dive, STAT (pharma), FDA press releases, FDA MedWatch, Drugs@FDA (new approvals), openFDA (Class I recalls)
2 stories
Tagged Immunology and inflammation from the headline and teaser, so some stories may be missed or misfiled.
- Trade pressBioPharma DiveNov 20, 2026Celldex drug stumbles in eczema; Epigenetic editing startup cuts staff
Wall Street analysts rushed to Celldex's defense following the setback. Elsewhere, Isomorphic Labs cut a cancer-focused deal with Merck and Teva's research chief accepted a new job.
- FDA approvalDrugs@FDAOct 23, 2026FDA new use approved: Skyrizi (Risankizumab-Rzaa), Abbvie INC
Efficacy supplement 53. Orphan, Priority review.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.